ReviewIntermediate

Performance Review

Performance review is the stage in which a validated strategy's results are judged honestly against a relevant benchmark and the original hypothesis, on a risk-adjusted basis and after realistic costs, in order to reach a disciplined keep-or-kill decision.

Quick Answer

Performance review judges a strategy against a fair benchmark such as holding the Nifty, not against zero, on a risk-adjusted, net-of-cost basis. It attributes the return to the hypothesised mechanism, discounts profits that rest on two or three outlier trades, and under genuine doubt defaults to kill, because the base rate of real edges is low.

Definition: Performance Review

Performance Review is the stage in which a validated strategy's results are judged against a relevant benchmark and the original hypothesis, risk-adjusted and after costs, to reach a keep-or-kill decision.

Key takeaways: Performance Review

  • Judge a strategy against a fair benchmark, not against zero
  • Use risk-adjusted, net-of-cost figures, not the headline return
  • Check that the return came from the mechanism the hypothesis predicted
  • Discount results that rely on a few outlier trades
  • Under doubt, the disciplined default is to kill

Performance Review at a glance

Performance Review — key facts at a glance, Indian backtesting context.
StageJudges results; keep-or-kill decision
BenchmarkFair investable alternative, not zero
Metric focusRisk-adjusted, net of costs
AttributionReturn must match the hypothesis
Warning signEdge resting on a few outlier trades
Default under doubtKill
Blind spotSelf-serving benchmark or short sample

Performance Review in simple words

Performance review is deciding whether a strategy is actually worth trading once the tests are done. That means comparing it to a fair benchmark, checking whether it did what your hypothesis said it would, and looking at risk and costs, not just the headline return. The hardest part is being willing to kill an idea you have grown attached to when the evidence says so. A high return that only came with huge drawdowns, or that a simple index beat, is not a success.

What Performance Review is for

This stage exists because raw profit is a misleading judge: a strategy is only worth keeping if it beats a fair benchmark on a risk-adjusted, cost-aware basis and confirmed the specific edge its hypothesis predicted.

Performance Review — professional explanation

Judge against a fair benchmark, not against zero

A positive return means little on its own; the real question is whether the strategy beat what you could have earned with less effort and risk. The correct benchmark is a relevant, investable alternative, such as buying and holding the Nifty for an equity strategy or a risk-free deposit rate for a market-neutral one. A strategy that returned a healthy figure but underperformed a simple index, after accounting for the extra risk and effort it demanded, has not earned its place. Choosing the benchmark honestly, and before seeing the result where possible, prevents the common trick of picking whichever comparison makes the strategy look best.

Risk-adjusted, not raw, performance

Two strategies with the same return are not equal if one reached it through far larger drawdowns. Honest review therefore looks at risk-adjusted measures such as the Sharpe or Sortino ratio, the maximum and average drawdown, and the length of the recovery period, alongside the return itself. A strategy whose equity curve lurches through deep drawdowns may be untradeable in practice because no human would sit through them, regardless of its final figure. The blind spot of any single number must be stated: a high Sharpe over a short or single-regime sample, for instance, can be an accident of the period rather than evidence of durable quality.

Did it confirm the hypothesis, or just make money

A crucial and often-skipped check is whether the strategy earned its return through the mechanism the hypothesis predicted, or through something incidental. If your hypothesis was a weekly mean-reversion edge but the profit actually came from a single large trending move, the hypothesis was not confirmed even though the account grew. Attributing the return to its source, by examining the trade distribution and when the gains occurred, distinguishes a genuine, repeatable edge from a lucky by-product. A strategy that made money for reasons unrelated to its thesis has no reason to keep working, and should be treated as unvalidated.

Costs, capacity and the shape of returns

Review must use net figures after realistic brokerage, taxes such as STT, and slippage, because a gross edge that costs consume is not an edge at all. It should also consider capacity, whether the strategy still works at the size you intend to trade, and the shape of the return stream, whether profits came from many independent trades or a handful of outliers. A result driven by two or three exceptional trades is fragile, because removing them collapses the edge, and it should be reviewed with far more scepticism than a broad, evenly distributed set of gains. The distribution of outcomes matters as much as their sum.

The keep, refine or kill decision

The review culminates in a decision, and the discipline is to make it against criteria set in advance rather than to rationalise whatever result appeared. Keep applies when the strategy beat its benchmark on a risk-adjusted, net basis and confirmed its hypothesis with a robust, well-distributed edge. Kill applies when it failed the benchmark, contradicted its thesis, or depended on a few lucky trades, and killing should be the default under doubt because the base rate of genuine edges is low. Refine is the narrow middle path, permissible only if the change is a new, pre-committed hypothesis validated on untouched data, never an excuse to keep tuning a failed idea until it passes.

Guarding against confirmation bias in review

By the time a strategy reaches review, the researcher has usually invested effort and formed an attachment, which makes confirmation bias acute: the temptation is to weigh favourable evidence heavily and explain away the rest. Countermeasures include writing the keep-or-kill criteria before seeing final results, seeking a second reviewer who did not build the strategy, and deliberately arguing the case for killing it. The healthiest research cultures reward killing bad strategies as much as launching good ones, because a disciplined kill protects capital that an attached, optimistic review would have quietly put at risk.

How Performance Review looks visually

Strategy LifecycleHypothesisBuildBacktestValidateDeployMonitorDecay /Retireiterate
Where performance review sits in the strategy lifecycle, feeding a keep, refine or kill decision.

Worked example: Performance Review

Illustrative example (Indian market)

A Nifty swing strategy on capital of Rs 5,00,000 shows a three-year net return that grew the account to Rs 7,35,000, a CAGR of about 13.7 percent, which looks satisfying in isolation. On review, the researcher compares it to simply holding the Nifty over the same period, which returned more with a smaller maximum drawdown, so on a risk-adjusted basis the strategy did not beat its benchmark. They also attribute the return and find that two trades during one trending quarter produced most of the gain, while the mean-reversion mechanism the hypothesis predicted contributed little. Because the strategy failed its benchmark, leaned on a couple of outliers, and did not confirm its thesis, the disciplined decision is to kill it, despite the positive headline number, since keeping it would mean trading an edge the evidence does not support.

Benchmark choice is consequential on NSE: an equity long strategy should be judged against a total-return Nifty index, and a costed comparison must include STT, stamp duty and exchange charges on both sides. A strategy that beats a price-return index but not a total-return one, or that only wins before costs, has not genuinely outperformed the simple alternative.

Honest review vs flattering review

Honest review vs flattering review — Performance Review, summarised for Indian F&O context.
AspectHonest reviewFlattering review
BenchmarkFair, chosen in advancePicked to make results look good
Metric focusRisk-adjusted and net of costsHeadline gross return
Return sourceAttributed to the hypothesisAccepted regardless of cause
Reliance on outliersChecked and discountedIgnored
Default under doubtKillKeep and rationalise

Limitations of Performance Review

  • Benchmarks are a matter of judgement, and an unfair or self-serving choice can make a weak strategy look good or a good one look weak
  • Risk-adjusted metrics have their own blind spots, so a single high ratio over a short or single-regime sample can mislead
  • Attributing returns to a mechanism is inexact, and a genuine edge can be temporarily masked by noise in a small sample
  • Keep-or-kill criteria set in advance still require judgement at the margin, where honest reviewers can disagree
  • Even a well-reviewed, kept strategy can decay after deployment, so review is a checkpoint rather than a permanent verdict

How professionals treat Performance Review

Institutional review judges a strategy against a fair, pre-chosen benchmark on a risk-adjusted, net-of-cost basis, and insists that the return be attributable to the hypothesised mechanism rather than to a handful of lucky trades. Keep-or-kill criteria are written before the final numbers are seen, an independent reviewer who did not build the strategy is often involved, and killing a bad idea is treated as a valued outcome rather than a failure. Under genuine doubt the default is to kill, because the base rate of real edges is low and the cost of trading a fitted strategy is paid in real capital.

Common misconceptions about Performance Review

Misconception: A good review means the strategy will keep working.

Reality: Review is a checkpoint based on the evidence available, not a permanent verdict, because markets change and edges decay after deployment. Even a strategy that beat its benchmark, confirmed its thesis and passed review must be monitored live and retired if its behaviour departs from the validated expectation.

Common mistakes with Performance Review

  • Judging a strategy by its raw return without comparing it to a fair, investable benchmark
  • Focusing on headline profit while ignoring drawdown, recovery time and risk-adjusted measures
  • Failing to attribute the return, so a profit from luck is mistaken for confirmation of the hypothesis
  • Reviewing on gross figures and discovering only later that costs and STT erase the edge
  • Keeping a strategy that relied on two or three outlier trades whose removal collapses the result
  • Rationalising a failed strategy into a keep instead of accepting the kill the evidence supports

Performance Review: frequently asked questions

What is performance review in the research process?

It is the stage where a validated strategy's results are judged honestly against a relevant benchmark and the original hypothesis, on a risk-adjusted, cost-aware basis, to reach a keep-or-kill decision. It exists because raw profit is a misleading judge, and a strategy earns its place only if it genuinely beats a fair alternative for a reason its thesis predicted.

Why compare a strategy to a benchmark?

Because a positive return is meaningless without knowing what you could have earned more simply. Comparing to an investable alternative, such as holding the Nifty or a risk-free rate, reveals whether the strategy's extra risk and effort were rewarded. A strategy that underperforms a simple index has not earned its place, however positive its own figure.

What is risk-adjusted performance?

It is performance measured relative to the risk taken to achieve it, using tools such as the Sharpe or Sortino ratio and drawdown measures, rather than the raw return alone. Two strategies with the same return are not equal if one endured far deeper drawdowns, so risk-adjusted figures are essential for an honest judgement of quality.

How do costs affect performance review?

Decisively, because a gross edge that realistic brokerage, taxes such as STT, and slippage consume is not an edge at all. Review must use net figures throughout, and many strategies that look profitable on gross numbers fail once the full cost of trading at the intended size and frequency is included.

How does confirmation bias affect performance review?

By the review stage the researcher is usually attached to the strategy, so there is a strong pull to weight favourable evidence and explain away the rest. Countermeasures include setting keep-or-kill criteria in advance, involving a reviewer who did not build the strategy, and deliberately arguing the case for killing it before deciding to keep it.

How is performance review different from validation?

Validation runs the technical tests that check whether an edge survives on unseen data, while performance review interprets those results to decide whether the strategy is worth trading. Validation asks whether the edge is real; review asks whether, given its risk, costs, benchmark and thesis, it is worth keeping. They are consecutive, complementary stages.

Sources & references

  • Bacon, C. R. (2008). Practical Portfolio Performance Measurement and Attribution (2nd ed.). John Wiley & Sons.

Published 11 July 2026. Educational content only — not investment advice. Markets and rules change; verify current conventions with SEBI, NSE/BSE and your broker.

Educational content only — not investment advice. Examples use illustrative numbers and simplified models. Backtested results are hypothetical and trading derivatives involves substantial risk. See our Risk Disclosure and SEBI Disclaimer.